TORONTO, March 21, 2016 /CNW/ - Isaac Maresky, Executive Director, Vaxil Bio Ltd. (VXL), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. Vaxil Bio Ltd. is an Israeli biotech company focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil Bio Ltd. commenced trading on TSX Venture Exchange on March 10, 2016. For more information please visit www.vxlbio.com.
SOURCE TMX Group Limited
Image with caption: "Isaac Maresky, Executive Director, Vaxil Bio Ltd. (VXL), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. Vaxil Bio Ltd. is an Israeli biotech company focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil Bio Ltd. commenced trading on TSX Venture Exchange on March 10, 2016. For more information please visit www.vxlbio.com. (CNW Group/TMX Group Limited)". Image available at: http://photos.newswire.ca/images/download/20160321_C5493_PHOTO_EN_647025.jpg
For more information please visit www.vxlbio.com.
Share this article